CoChat

Practical cut‐offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment

Open access
Ferreira, D., Cavallin, L., Larsson, E.‐M., Muehlboeck, J.‐S., Mecocci, P., Vellas, B., Tsolaki, M., Kłoszewska, I., Soininen, H., Lovestone, S., Simmons, A., Wahlund, L.‐O., Westman, E., the AddNeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative · 2015 · Journal of Internal Medicine
Cited by 121

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Background: Atrophy in the medial temporal lobe, frontal lobe and posterior cortex can be measured with visual rating scales such as the medial temporal atrophy (MTA), global cortical atrophy – frontal subscale (GCA‐F) and posterior atrophy (PA) scales, respectively. However, practical cut‐offs are urgently needed, especially now that different presentations of Alzheimer's disease (AD) are included in the revised diagnostic criteria. Aims: The aim of this study was to generate a list of practical cut‐offs for the MTA, GCA‐F and PA scales, for both diagnosis of AD and determining prognosis in mild cognitive impairment (MCI), and to evaluate the influence of key demographic and clinical factors on these cut‐offs. Methods: AddNeuroMed and ADNI cohorts were combined giving a total of 1147 participants (322 patients with AD, 480 patients with MCI and 345 control subjects). The MTA, GCA‐F and PA scales were applied and a broad range of cut‐offs was evaluated. Results: The MTA scale showed better diagnostic and predictive performances than the GCA‐F and PA scales. Age, apolipoprotein E (ApoE) ε4 status and age at disease onset influenced all three scales. For the age ranges 45–64, 65–74, 75–84 and 85–94 years, the following cut‐offs should be used. MTA: ≥1.5, ≥1.5, ≥2 and ≥2.5; GCA‐F, ≥1, ≥1, ≥1 and ≥1; and PA, ≥1, ≥1, ≥1 and ≥1, respectively, with an adjustment for early‐onset ApoE ε4 noncarrier AD patients (MTA: ≥2, ≥2, ≥3 and ≥3; and GCA‐F: ≥1, ≥1, ≥2 and ≥2, respectively). Conclusions: If successfully validated in clinical settings, the list of practical cut‐offs proposed here might be useful in clinical practice. Their use might also (i) promote research on atrophy subtypes, (ii) increase the understanding of different presentations of AD, (iii) improve diagnosis and prognosis and (iv) aid population selection and enrichment for clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/joim.12358

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 121

Metadata

Authors
Ferreira, D., Cavallin, L., Larsson, E. ‐., Muehlboeck, J. ‐., Mecocci, P., Vellas, B., Tsolaki, M., Kłoszewska, I., Soininen, H., Lovestone, S., Simmons, A., Wahlund, L. ‐., Westman, E., & the AddNeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
2015-04-13
Volume
278
Issue
3
Pages
277-290
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W1995881350
Cited by
121
References
13
FWCI
7.72
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Practical cut‐offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment. https://app.cochat.ai/papers/10.1111/joim.12358
The paper
Ferreira, D., Cavallin, L., Larsson, E. ‐., Muehlboeck, J. ‐., Mecocci, P., Vellas, B., Tsolaki, M., Kłoszewska, I., Soininen, H., Lovestone, S., Simmons, A., Wahlund, L. ‐., Westman, E., & the AddNeuroMed consortium and the Alzheimer's Disease Neuroimaging Initiative. (2015). Practical cut‐offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment. Journal of Internal Medicine. https://doi.org/10.1111/joim.12358

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.